By Khushi Malhotra and Dharamraj Dhutia MUMBAI, Sept 29 (Reuters) – India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-denominated debt
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)